Abstract
The aim of current study is to synthesize a theranostic (multi-functional) agent, which is targeted on ovary, cervical and breast cancer types with diagnosis and treatment potential and to determine its bioaffinity by using in vitro methods. In conclusion; the designed compound (IPPP), which has fluorescence capability (from Indocyanine), encapsulated structure (with PEGylated PLGA), included an anticancer drug (Paclitaxel) for targeting and radionuclidic tracer (131I) content for tracing, has bioaffinity and promise for diagnosis and therapy on ovarian, cervical and breast cancer cell lines.
Similar content being viewed by others
References
Davis SS (1997) Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Trends Biotechnol 15:217–224
Vij N, Min T, Marasigan R, Belcher CN, Mazur S, Ding H, Yong KT, Roy I (2010) Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis. J Nanobiotechnol 8(22):1–18
Sahoo SK, Panyam J, Prabha S, Labhasetwar V (2002) Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 82:105–114
Panyam J, Labhasetwar V (2003) Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 55:329–437
McCarron PA, Hall M (2004) Pharmaceutical nanotechnology. Encycl Nanosci Nanotechnol 8:469–487
Li YP, Pei YY, Zhang XY, Gu ZH, Zhou ZH, Yuan WF, Zhou JJ, Zhu JH, Gao XJ (2001) PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release 71:203–211
Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R (1994) Biodegradable long-circulating polymeric nanospheres. Science 263:1600–1603
Jeong B, Bae YH, Kim SW (2000) Drug release from biodegradable injectable thermosensitive hydrogel of PEG–PLGA–PEG triblock copolymers. J Control Release 63:155–163
Mérian J, Gravier J, Navarro F, Texier I (2012) Fluorescent nanoprobes dedicated to in vivo imaging: from preclinical validations to clinical translation. Molecules 17:5564–5591
Kuo WS, Chang YT, Cho KC, Chiu KC, Lien CH, Yeh CS (2012) Gold nanomaterials conjugated with indocyanine green for dual-modality photodynamic and photothermal therapy. Biomaterials 33:3270–3278
Saxena V, Sadoqi M, Shao J (2004) Enhanced photo-stability, thermal-stability and aqueous-stability of indocyanine green in polymeric nanoparticulate systems. J Photochem Photobiol, B 74:29–38
Saxena V, Sadoqi M, Shao J (2006) Polymeric nanoparticulate delivery system for indocyanine green: biodistribution in healthy mice. Int J Pharm 308:200–204
Sheng Z, Hu D, Xue M, He M, Gong P, Cai L (2013) Indocyanine green nanoparticles for theranostic applications. Nano-Micro Lett 5:145–150
Larush L, Magdassi S (2011) Formation of near-infrared fluorescent nanoparticles for medical imaging. Nanomedicine 6:233–240
Gomes AJ, Lunardi LO, Marchetti JM, Lunardi CN, Tedesco AC (2006) Indocyanine green nanoparticles useful for photomedicine. Photomed Laser Surg 24:514–521
Xu RX, Huang J, Xu JS, Sun D, Hinkle GH, Martin EW, Povoski SP (2009) Fabrication of indocyanine green encapsulated biodegradable microbubbles for structural and functional imaging of cancer. J Biomed Opt 14:034020
Patel RH, Wadajkar AS, Patel NL, Kavuri VC, Nguyen KT, Liu H (2012) Multifunctionality of indocyanine green-loaded biodegradable nanoparticles for enhanced optical imaging and hyperthermia intervention of cancer. J Biomed Opt 17:046003
Miki K, Oride K, Inoue S, Kuramochi Y, Nayak RR, Matsuoka H, Harada H, Hiraoka M, Ohe K (2010) Ring-opening metathesis polymerization-based synthesis of polymeric nanoparticles for enhanced tumor imaging in vivo: synergistic effect of folate-receptor targeting and PEGylation. Biomaterials 31:934–942
Bahmani B, Bacon D, Anvari B (2013) Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications. Sci Rep 3(2180):1–7
Alacam B, Yazici B, Intes X, Nioka S, Chance B (2008) Pharmacokinetic-rate images of indocyanine green for breast tumors using near-infrared optical methods. Phys Med Biol 53:837–859
Tsuchimochi M, Hayama K, Toyama M, Sasagawa I, Tsubokawa N (2013) Dual-modality imaging with 99mTc and fluorescent indocyanine green using surface-modified silica nanoparticles for biopsy of the sentinel lymph node: an animal study. EJNMMI Res 3:33–44
Kisu I, Banno K, Yanokura M, Nogami Y, Umene K, Tsuji K, Masuda K, Ueki A, Kobayashi Y, Aoki D (2013) Indocyanine green fluorescence imaging in the pregnant cynomolgus macaque: childbearing is supported by a unilateral uterine artery and vein alone? Arch Gynecol Obstet 288:1309–1315
Ma Y, Sadoqi M, Shao J (2012) Biodistribution of indocyanine green-loaded nanoparticles with surface modifications of PEG and folic acid. Int J Pharm 436:25–31
Zheng M, Yue C, Ma Y, Gong P, Zhao P, Zheng C, Sheng Z, Zhang P, Wang Z, Cai L (2013) Single-step assembly of DOX/ICG loaded lipid–polymer nanoparticles for highly effective chemo-photothermal combination therapy. ACS Nano 7:2056–2067
Zhong J, Yang S, Zheng X, Zhou T, Xing D (2013) In vivo photoacoustic therapy with cancer-targeted indocyanine green-containing nanoparticles. Nanomedicine 8:903–919
Van der Poel HG, Buckle T, Brouwer OR, Olmos RAV, van Leeuwen FWB (2011) Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol 60:826–833
Brouwer OR, Buckle T, Vermeeren L, Klop WMC, Balm AJM, van der Poel HG, van Rhijn BW, Horenblas S, Nieweg OE, van Leeuwen FWB, Olmos RAV (2012) Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med 53:1034–1040
Acharya S, Sahoo SK (2011) PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:170–183
Thigpen JT (2000) Chemotherapy for advanced ovarian cancer: overview of randomized trials. Semin Oncol 27:11–16
Chang AY, Rubins J, Asbury R, Boros L, Hui LF (2001) Weekly paclitaxel in advanced non-small cell lung cancer. Semin Oncol 28:10–13
Fonseca C, Simões S, Gaspar R (2002) Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release 83:273–286
Chen X, Gambhir SS, Cheon J (2011) Theranostic nanomedicine. Acc Chem Res 44:841
Liu Y, Yu G, Tian M, Zhang H (2011) Optical probes and the applications in multimodality imaging. Contrast Media Mol Imaging 6:169–177
Jennings LE, Long NJ (2009) “Two is better than one”—probes for dual-modality molecular imaging. Chem Commun (Camb) 24:3511–3524
Janib SM, Moses AS, MacKay JA (2010) Imaging and drug delivery using theranostic nanoparticles. Adv Drug Deliv Rev 62:1052–1063
Kelkar SS, Reineke TM (2011) Theranostics: combining imaging and therapy. Bioconjug Chem 22:1879–1903
Saha GB (2010) Fundamentals of nuclear pharmacy. Springer, New York
Unak P, Cetinkaya B (2005) Absorbed dose estimates at the cellular level for 131I. Appl Radiat Isot 62:861–869
Blankenberg FG, Strauss HW (2002) Nuclear medicine applications in molecular imaging. J Magn Reson Imaging 16:352–361
Muhammad HM, Saour KY, Naqishbandi AM (2009) Quantitative and qualitative analysis of plumbagin in the leaf and root of plumbago Europaea growing naturally in Kurdistan by HPLC introduction. J Pharm Sci 18:54–59
Ozkan M, Biber Muftuler FZ, Yurt Kilcar A, Medine EI, Unak P (2013) Isolation of hydroxytyrosol from olive leaves extract, radioiodination and investigation of bioaffinity using in vivo/in vitro methods. Radiochim Acta 101:585–593
Tekin V, Kozgus Guldu O, Yurt Kilcar A, Medine EI, Yavuz M, Unak P, Timur S (2015) Evaluation of Lawsonia inermis Origin Lawsone compound and its radioiodinated form via in vitro methods. J Radioanal Nucl Chem 303(1):701–708
Medine IE, Unak P, Sakarya S, Toksöz F (2010) Enzymatic synthesis of uracil glucuronide, labeling with 125/131I, and in vitro evaluation on adenocarcinoma cells. Cancer Biother Radiopharm 25:335–344
Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC (2007) Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials 28:869–876
Medine EI, Odaci D, Gacal BN, Gacal B, Sakarya S, Unak P, Timur S, Yagci Y (2010) A new approach for in vitro imaging of breast cancer cells by anti-metadherin targeted PVA-pyrene. Macromol Biosci 10:657–663
Ediz M, Avcıbaşı U, Unak P, Biber Muftuler FZ, Medine EI, Yurt Kilcar A, Demiroglu H, Gumuser FG, Sakarya S (2013) Investigation of therapeutic efficiency of bleomycin and bleomycin-glucuronide labeled with 131I on the cancer cell lines. Cancer Biother Radiopharm 28:310–319
Cekic B, Yurt Kilcar A, Biber Muftuler FZ, Unak P, Medine EI (2012) Radiolabeling of methanol extracts of yarrow (Achillea millefolium l) in rats. Acta Cir Bras 27:294–300
Fraker PJ, Speck JC (1978) Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem Biophys Res Commun 80:849–857
Bahmani B, Lytle CY, Walker AM, Gupta S, Vullev V, Anvari B (2013) Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs. Int J Nanomed 8:1609–1620
Acknowledgments
This work is supported by Ege University Research Fund (contract no 2014-TIP-085). The authors thank to Emine Derviş, Tansu Doğan, Ezgi Sulu, Onur Yıldız, Göksu Işık, Alper Kan and Büşra Karatay for the technical assistance during the in vitro experiments.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Akman, L., Biber Muftuler, F.Z., Bilgi, A. et al. Synthesis of a theranostic agent: radioiodinated PEGylated PLGA-indocyanine capsules and in vitro determination of their bioaffinity on ovarian, cervical and breast cancer cells. J Radioanal Nucl Chem 308, 659–670 (2016). https://doi.org/10.1007/s10967-015-4472-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-015-4472-z